Basic Information
Basic information for LINC01876-210-45aa-2
Peptide Name LINC01876-210-45aa-2
Genome Position chr2:156020540-156020641,156022785-156022817[-]
Species Human
Peptide Sequence MTDAWVRTHNTFLFISTKILRSTAPPTCHTLGRDYWNASWIRYLW
Peptide Length 45
Unique No (LINC01876-201-45aa-2,LINC01876-202-45aa,LINC01876-203-45aa,LINC01876-204-45aa,LINC01876-207-45aa,LINC01876-208-45aa,LINC01876-209-45aa-3,LINC01876-211-45aa-2,LINC01876-212-45aa-2,LINC01876-213-45aa-3)
Grand Average of Hydropathicity -0.2467
Relative Molecular Mass 6221.09
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000226383;LINC01876
Transcript ID/Name ENST00000657334;LINC01876-210
Transcript Length 1770
Coding Ability 0.3847
DNA Sequence Corresponding to Peptide ATGACGGATGCCTGGGTCAGAACACATAATACATTCCTTTTTATAAGCACAAAGATTCTGAGAAGCACTGCCCCTCCCACGTGTCACACTCTGGGGAGAGATTATTGGAATGCCTCTTGGATCAGGTATCTTTGG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :